- Thursday, March 28, 2024
7:00 AM – 8:00 AM MDT
Network/Community Networking Breakfast brought to you by Pfizer
7:00 AM – 8:00 AM MDT
Network/Community Networking Breakfast brought to you by Pfizer
Location: Colorado Hall
7:00 AM – 6:30 PM MDT
ASCPT Central
7:00 AM – 6:30 PM MDT
Registration and ASCPT Info Desk
Location: Broadmoor Hall
7:00 AM – 6:30 PM MDT
Speaker Ready Room
7:00 AM – 6:30 PM MDT
Speaker Ready Room
Location: Broadmoor Hall C
8:15 AM – 9:15 AM MDT
State of the Art Lecture - Kelly Chibale
8:15 AM – 9:15 AM MDT
State of the Art Lecture - Kelly ChibaleLocation: Broadmoor Hall BState of the Art Speaker: – H3D Research Centre, University of Cape Town
Moderator: – Thomas Jefferson University
Infectious Diseases (INF)
Kelly Chibale, PhD – H3D Research Centre, University of Cape Town ### 2143324###State of the Art Speaker###Founder and Director###H3D Research Centre, University of Cape Town###State of the Art Speaker: – H3D Research Centre, University of Cape Town
### @@@ Walter Kraft, MD – Thomas Jefferson University ### 1436017###Moderator###Professor###Thomas Jefferson University###Moderator: – Thomas Jefferson University
### 9:00 AM – 5:00 PM MDT
Posters Available for Viewing (Unattended)
9:00 AM – 5:00 PM MDT
Posters Available for Viewing (Unattended)
Location: Bartolin Hall
9:00 AM – 6:30 PM MDT
Partner Hub
9:00 AM – 6:30 PM MDT
Partner Hub
Location: Bartolin Hall
9:30 AM – 10:30 AM MDT
Is Pharmacogenetic Testing a Vital Tool for Enhancing Therapeutic Management of Patients Worldwide?
9:30 AM – 10:30 AM MDT
Is Pharmacogenetic Testing a Vital Tool for Enhancing Therapeutic Management of Patients Worldwide?Location: Broadmoor Hall AChair: – Certara
Chair: – University of California, San Francisco
Speaker: – Leiden University Medical Center
Speaker: – Tufts University School of Medicine
Speaker: – University of Montana
Speaker: – National Institute of Health
Pharmacogenomics (PGx)
Special Populations (SPO)
Piet H. van der Graaf, PharmD, PhD – Certara ### 1485757###Chair###Senior Vice President and Professor of Systems Pharmacology###Certara###Chair: – Certara
### @@@ Kathleen M. Giacomini, PhD – University of California, San Francisco ### 1429074###Chair###Professor and Dean, School of Pharmacy###University of California, San Francisco###Chair: – University of California, San Francisco
### @@@ Henk-Jan Guchelaar, PharmD, PhD – Leiden University Medical Center ### 1143253###Speaker###Professor###Leiden University Medical Center###Speaker: – Leiden University Medical Center
### @@@ David J. Greenblatt, MD (he/him/his) – Tufts University School of Medicine ### 1436029###Speaker###Professor###Tufts University School of Medicine###Speaker: – Tufts University School of Medicine
### he/him/his @@@ Karen E. Brown, PharmD – University of Montana ### 1502602###Speaker###Principal Scientist###University of Montana###Speaker: – University of Montana
### @@@ Neil Hanchard, MD, PhD – National Institute of Health ### 1429094###Speaker###Senior Investigator###National Institute of Health###Speaker: – National Institute of Health
### 9:30 AM – 10:30 AM MDT
Meet the Expert in the Real-World: Real-World Data in Drug Development and Utilization - Part 1
9:30 AM – 10:30 AM MDT
Meet the Expert in the Real-World: Real-World Data in Drug Development and Utilization - Part 1Location: Broadmoor Hall BChair: – Clalit Health Services, and Rappaport Faculty of Medicine, Technion - Israel Institue of Technology
Chair: – Pfizer, Inc.
Speaker: – GlaxoSmithKline
Speaker: – IQVIA
Speaker: – Harvard Medical School
Drug Utilization & Outcomes (DUO)
Life Cycle Management (LCM)
Naomi Gronich, MD (she/her/hers) – Clalit Health Services, and Rappaport Faculty of Medicine, Technion - Israel Institue of Technology ### 1819741###Chair###Physician###Clalit Health Services, and Rappaport Faculty of Medicine, Technion - Israel Institue of Technology###Chair: – Clalit Health Services, and Rappaport Faculty of Medicine, Technion - Israel Institue of Technology
### she/her/hers @@@ Mohamed Elmeliegy, PhD, MBA – Pfizer, Inc. ### 2130797###Chair###Director, Oncology Clinical Pharmacology###Pfizer, Inc.###Chair: – Pfizer, Inc.
### @@@ Linda Kalilani, MBBS, MPH, PhD – GlaxoSmithKline ### 2121854###Speaker###Senior Director & Head of Oncology Epidemiology ###GlaxoSmithKline###Speaker: – GlaxoSmithKline
### @@@ Emily Bratton, PhD (she/her/hers) – IQVIA ### 2121855###Speaker###Category Lead, Real World Solutions###IQVIA###Speaker: – IQVIA
### she/her/hers @@@ Elisabetta Patorno, MD, PhD – Harvard Medical School ### 2121857###Speaker###Associate Professor of Medicine###Harvard Medical School###Speaker: – Harvard Medical School
### 9:30 AM – 10:30 AM MDT
Transporter Research for Global Outreach: Unleashing the Power of Everything, Everywhere, All at Once
9:30 AM – 10:30 AM MDT
Transporter Research for Global Outreach: Unleashing the Power of Everything, Everywhere, All at OnceLocation: International Center NorthChair: – University of California, San Francisco
Chair: – Genentech
Speaker: – US Food and Drug Administration
Speaker: – University of Washington
Speaker: – Certara UK (Simcyp Division)
Membrane Transporter (MT)
Physiological Based Pharmacokinetic Modeling and Simulation (PBPK)
Sook Wah Yee, PhD – University of California, San Francisco ### 1770960###Chair###Associate Adjunct Professor###University of California, San Francisco###Chair: – University of California, San Francisco
### @@@ Kit Wun Kathy Cheung, PharmD (she/her/hers) – Genentech ### 1770961###Chair###Principal Scientist, Clinical Pharmacology###Genentech###Chair: – Genentech
### she/her/hers @@@ Vikram Arya, PhD (he/him/his) – US Food and Drug Administration ### 1429056###Speaker###Associate Director for Therapeutic Review (ADTR)###US Food and Drug Administration###Speaker: – US Food and Drug Administration
### he/him/his @@@ Jashvant D. Unadkat, PhD (he/him/his) – University of Washington ### 2121880###Speaker###Professor###University of Washington###Speaker: – University of Washington
### he/him/his @@@ Sibylle Neuhoff, PhD (she/her/hers) – Certara UK (Simcyp Division) ### 1187891###Speaker###Senior Scientific Adviser###Certara UK (Simcyp Division)###Speaker: – Certara UK (Simcyp Division)
### she/her/hers10:30 AM – 11:00 AM MDT
Learning Lab brought to you by Celerion: Drug-Drug Interaction Happy Hour: Best Practices for Cocktail Studies
10:30 AM – 11:00 AM MDT
Learning Lab brought to you by Celerion: Drug-Drug Interaction Happy Hour: Best Practices for Cocktail Studies Location: Broadmoor EPartner Presenter: – Celerion
Aernout D. van Haarst, PhD (he/him/his) – Celerion ### 1847903###Partner Presenter###Director Scientific Affairs###Celerion###Partner Presenter: – Celerion
### he/him/his10:30 AM – 11:00 AM MDT
Learning Lab brought to you by Parexel: Unlocking Clinical Trial Success: Harnessing Data-driven Approaches to Select the Right Dose, Right Site, and Right Patient
10:30 AM – 11:00 AM MDT
Learning Lab brought to you by Parexel: Unlocking Clinical Trial Success: Harnessing Data-driven Approaches to Select the Right Dose, Right Site, and Right PatientLocation: Broadmoor FPartner Presenter: – Parexel
Partner Presenter: – Parexel International
Angela Qu, MD, PhD (she/her/hers) – Parexel ### 2288287###Partner Presenter######Parexel###Partner Presenter: – Parexel
### she/her/hers @@@ Ana Novakovic – Parexel International ### 1819430###Partner Presenter######Parexel International###Partner Presenter: – Parexel International
### 10:30 AM – 11:00 AM MDT
Meet ASCPT Leaders
10:30 AM – 11:00 AM MDT
Meet ASCPT LeadersLocation: Bartolin HallExpert:
Expert: – Pfizer, Inc.
Abigail Gorman ### 2289633###Expert#########Expert:
### @@@ Mohamed Shahin, PhD, MS – Pfizer, Inc. ### 1819280###Expert###Clinical Pharmacologist###Pfizer, Inc.###Expert: – Pfizer, Inc.
### 10:30 AM – 11:00 AM MDT
Networking Break brought to you by IntiQuan
10:30 AM – 11:00 AM MDT
Networking Break brought to you by IntiQuan
Location: Bartolin Hall
10:40 AM – 10:55 AM MDT
Micro-Learning Lounge brought to you by ICON: Strategic Approaches and Best Practices in First-in-Human Studies and Early Clinical Development
10:40 AM – 10:55 AM MDT
Micro-Learning Lounge brought to you by ICON: Strategic Approaches and Best Practices in First-in-Human Studies and Early Clinical DevelopmentLocation: Bartolin HallPartner Presenter: – ICON
Jocelyn Courville, MBA, MS, PhD – ICON ### 2260466###Partner Presenter###Director of Clinical Pharmacology###ICON###Partner Presenter: – ICON
### 11:00 AM – 11:45 AM MDT
Featured Speaker - Kelly Dooley
11:00 AM – 11:45 AM MDT
Featured Speaker - Kelly DooleyLocation: Broadmoor Hall BFeatured Speaker: – Vanderbilt University Medical Center
Moderator: – Thomas Jefferson University
Kelly E. Dooley, MD, MPH, PhD (she/her/hers) – Vanderbilt University Medical Center ### 1156649###Featured Speaker###Professor of Medicine###Vanderbilt University Medical Center###Featured Speaker: – Vanderbilt University Medical Center
### she/her/hers @@@ Walter Kraft, MD – Thomas Jefferson University ### 1436017###Moderator###Professor###Thomas Jefferson University###Moderator: – Thomas Jefferson University
### 11:00 AM – 11:45 AM MDT
Leon I. Goldberg Early Investigator Award Lecture
11:00 AM – 11:45 AM MDT
Leon I. Goldberg Early Investigator Award LectureLocation: Broadmoor Hall AAward Lecturer: – University of Southern California
Award Presenter: – University of North Carolina at Chapel Hill
Infectious Diseases (INF)
Systems Pharmacology (SP)
Gauri G. Rao, PharmD (she/her/hers) – University of Southern California ### 863700###Award Lecturer###Associate Professor###University of Southern California###Award Lecturer: – University of Southern California
### she/her/hers @@@ Kim Brouwer, PharmD, PhD – University of North Carolina at Chapel Hill ### 830449###Award Presenter###Associate Dean for Research and Graduate Education
UNC Eshelman School of Pharmacy###University of North Carolina at Chapel Hill###Award Presenter: – University of North Carolina at Chapel Hill
### 11:00 AM – 12:00 PM MDT
Equity, Data, and Representation in Real-World Clinical Trials and Virtual Populations
11:00 AM – 12:00 PM MDT
Equity, Data, and Representation in Real-World Clinical Trials and Virtual PopulationsLocation: International Center NorthChair: – Simulations Plus
Chair: – Duke University
Speaker: – US Food and Drug Administration
Speaker: – Simulations Plus
Speaker: – University at Buffalo
Systems Pharmacology (SP)
Special Populations (SPO)
Kyunghee Yang, PhD (she/her/hers) – Simulations Plus ### 1184502###Chair###Sr. Principal Scientist###Simulations Plus###Chair: – Simulations Plus
### she/her/hers @@@ Daniel Gonzalez, PharmD, PhD (he/him/his) – Duke University ### 2121860###Chair###Instructor###Duke University###Chair: – Duke University
### he/him/his @@@ Qi Liu, PhD – US Food and Drug Administration ### 867595###Speaker###Associate Director for Innovation & Partnership, Office of Clinical Pharmacology###US Food and Drug Administration###Speaker: – US Food and Drug Administration
### @@@ Jeffrey L. Woodhead, PhD (he/him/his) – Simulations Plus ### 2121861###Speaker###Senior Principal Scientist###Simulations Plus###Speaker: – Simulations Plus
### he/him/his @@@ Murali Ramanathan, PhD (he/him/his) – University at Buffalo ### 2121862###Speaker###Professor###University at Buffalo###Speaker: – University at Buffalo
### he/him/his11:00 AM – 12:00 PM MDT
Novel Advancements in the Treatment of Mood and Anxiety Disorders in Children and Perspectives on Implementation and Outreach in Underserved Communities
11:00 AM – 12:00 PM MDT
Novel Advancements in the Treatment of Mood and Anxiety Disorders in Children and Perspectives on Implementation and Outreach in Underserved CommunitiesLocation: International Center SouthChair: – Mind Medicine
Chair: – Children's Mercy Kansas City
Speaker: – University of Cincinnati
Speaker: – Children's Mercy Kansas City
Speaker: – Mayo Clinic
Speaker: – University of Montana
Mental Health & Addiction (MHA)
Early Career (EC)
Nithya Srinivas, PhD (she/her/hers) – Mind Medicine ### 1819207###Chair###Director, Clinical Pharmacology ###Mind Medicine ###Chair: – Mind Medicine
### she/her/hers @@@ Stephani L. Stancil, PhD (she/her/hers) – Children's Mercy Kansas City ### 1214019###Chair###Assistant Professor###Children's Mercy Kansas City###Chair: – Children's Mercy Kansas City
### she/her/hers @@@ Jeffrey Robert Strawn, MD (he/him/his) – University of Cincinnati ### 1144053###Speaker###Professor of Psychiatry###University of Cincinnati###Speaker: – University of Cincinnati
### he/him/his @@@ Stephani L. Stancil, PhD (she/her/hers) – Children's Mercy Kansas City ### 1214019###Speaker###Assistant Professor###Children's Mercy Kansas City###Speaker: – Children's Mercy Kansas City
### she/her/hers @@@ Arjun Athreya, PhD, MSc – Mayo Clinic ### 2121849###Speaker###Assistant Professor of Pharmacology & Psychiatry###Mayo Clinic###Speaker: – Mayo Clinic
### @@@ Erica L. Woodahl, PhD (she/her/hers) – University of Montana ### 1144011###Speaker###Professor###University of Montana###Speaker: – University of Montana
### she/her/hers11:30 AM – 6:30 PM MDT
Headshot Lounge brought to you by Metrum Research Group
11:30 AM – 6:30 PM MDT
Headshot Lounge brought to you by Metrum Research Group
Location: Bartolin Hall
12:00 PM – 1:30 PM MDT
Networking Lunch brought to you by GalenusRx
12:00 PM – 1:30 PM MDT
Networking Lunch brought to you by GalenusRx
Location: Colorado Hall
12:15 PM – 12:45 PM MDT
Learning Lab brought to you by Certara: Bespoke Comprehensive Cardiac Safety Support at Certara and Recent Experience with C-QTc modeling in Special Populations
12:15 PM – 12:45 PM MDT
Learning Lab brought to you by Certara: Bespoke Comprehensive Cardiac Safety Support at Certara and Recent Experience with C-QTc modeling in Special PopulationsLocation: Broadmoor Hall FPartner Presenter: – Certara
Partner Presenter: – Certara Drug Development Solutions
Amy Cheung, PhD (she/her/hers) – Certara ### 1472464###Partner Presenter###Vice President###Certara###Partner Presenter: – Certara
### she/her/hers @@@ Mark Shelton, PharmD – Certara Drug Development Solutions ### 2275982###Partner Presenter###Senior Director###Certara Drug Development Solutions###Partner Presenter: – Certara Drug Development Solutions
### 12:15 PM – 1:15 PM MDT
Learning Lab brought to you by Centre for Human Drug Research (CHDR): How CHDR Adds Value to Early Phase Clinical Drug Studies: Development and Validation of Methodology to Prove Pharmacology in Healthy Subjects and Demonstrate Target Engagement in Patients
12:15 PM – 1:15 PM MDT
Learning Lab brought to you by Centre for Human Drug Research (CHDR): How CHDR Adds Value to Early Phase Clinical Drug Studies: Development and Validation of Methodology to Prove Pharmacology in Healthy Subjects and Demonstrate Target Engagement in PatientsLocation: Broadmoor Hall EPartner Presenter:
Partner Presenter: – Centre for Human Drug Research
Partner Presenter:
Geert Jan Groeneveld ### 2288218###Partner Presenter#########Partner Presenter:
### @@@ Koos Burggraaf, PhD – Centre for Human Drug Research ### 2288219###Partner Presenter######Centre for Human Drug Research###Partner Presenter: – Centre for Human Drug Research
### @@@ Robert Rissman ### 2288220###Partner Presenter#########Partner Presenter:
### 1:30 PM – 2:30 PM MDT
Meet the Expert in the Real-World: Real-World Data in Drug Development and Utilization - Part 2
1:30 PM – 2:30 PM MDT
Meet the Expert in the Real-World: Real-World Data in Drug Development and Utilization - Part 2Location: Broadmoor Hall AChair: – Clalit Health Services, and Rappaport Faculty of Medicine, Technion - Israel Institue of Technology
Chair: – Pfizer, Inc.
Speaker: – GlaxoSmithKline
Speaker: – IQVIA
Speaker: – Harvard Medical School
Drug Utilization & Outcomes (DUO)
Life Cycle Management (LCM)
Naomi Gronich, MD (she/her/hers) – Clalit Health Services, and Rappaport Faculty of Medicine, Technion - Israel Institue of Technology ### 1819741###Chair###Physician###Clalit Health Services, and Rappaport Faculty of Medicine, Technion - Israel Institue of Technology###Chair: – Clalit Health Services, and Rappaport Faculty of Medicine, Technion - Israel Institue of Technology
### she/her/hers @@@ Mohamed Elmeliegy, PhD, MBA – Pfizer, Inc. ### 2130797###Chair###Director, Oncology Clinical Pharmacology###Pfizer, Inc.###Chair: – Pfizer, Inc.
### @@@ Linda Kalilani, MBBS, MPH, PhD – GlaxoSmithKline ### 2121854###Speaker###Senior Director & Head of Oncology Epidemiology ###GlaxoSmithKline###Speaker: – GlaxoSmithKline
### @@@ Emily Bratton, PhD (she/her/hers) – IQVIA ### 2121855###Speaker###Category Lead, Real World Solutions###IQVIA###Speaker: – IQVIA
### she/her/hers @@@ Elisabetta Patorno, MD, PhD – Harvard Medical School ### 2121857###Speaker###Associate Professor of Medicine###Harvard Medical School###Speaker: – Harvard Medical School
### 1:30 PM – 3:00 PM MDT
Patient Forum
1:30 PM – 3:00 PM MDT
Patient ForumLocation: Broadmoor Hall BChair: – Koneksa Health
Speaker: – Critical Path Institute
Speaker: – Critical Path For Parkinson's
Speaker: – US Food and Drug Administration
Speaker: – Rho, Inc.
John Wagner, MD, PhD (he/him/his) – Koneksa Health ### 1201986###Chair###Chief Medical Officer###Koneksa Health###Chair: – Koneksa Health
### he/him/his @@@ Diane Stephenson, PhD – Critical Path Institute ### 1429065###Speaker###Executive Director###Critical Path Institute###Speaker: – Critical Path Institute
### @@@ Sarah Zenner-Dolan (she/her/hers) – Critical Path For Parkinson's ### 2173787###Speaker###Patient###Critical Path For Parkinson's###Speaker: – Critical Path For Parkinson's
### she/her/hers @@@ Qi Liu, PhD – US Food and Drug Administration ### 867595###Speaker###Associate Director for Innovation & Partnership, Office of Clinical Pharmacology###US Food and Drug Administration###Speaker: – US Food and Drug Administration
### @@@ Peter Schmidt, PhD (he/him/his) – Rho, Inc. ### 2236082###Speaker###Chief Scientific Officer###Rho, Inc.###Speaker: – Rho, Inc.
### he/him/his3:00 PM – 3:30 PM MDT
Learning Lab brought to you by Fortrea: Managing Complexity in Early Phase Clinical Trials
3:00 PM – 3:30 PM MDT
Learning Lab brought to you by Fortrea: Managing Complexity in Early Phase Clinical TrialsLocation: Broadmoor Hall FPartner Presenter: – Fortrea
Oren Cohen, MD – Fortrea ### 2260471###Partner Presenter###Chief Medical Officer and President, Clinical Pharmacology Services###Fortrea###Partner Presenter: – Fortrea
### 3:00 PM – 3:30 PM MDT
Meet ASCPT Leaders
3:00 PM – 3:30 PM MDT
Meet ASCPT LeadersLocation: Bartolin HallExpert: – Pfizer, Inc.
Expert: – Johnson & Johnson
Jing Liu, PhD (she/her/hers) – Pfizer, Inc. ### 1770945###Expert###Sr Director###Pfizer, Inc.###Expert: – Pfizer, Inc.
### she/her/hers @@@ Daniele Ouellet, PhD – Johnson & Johnson ### 1429066###Expert###Global Head Clinical Pharmacology & Pharmacometrics###Johnson & Johnson###Expert: – Johnson & Johnson
### 3:00 PM – 3:30 PM MDT
Networking Break brought to you by Takeda
3:00 PM – 3:30 PM MDT
Networking Break brought to you by Takeda
Location: Bartolin Hall
3:30 PM – 4:15 PM MDT
2023 Darrell Abernethy Early Stage Investigator Award Lecture
3:30 PM – 4:15 PM MDT
2023 Darrell Abernethy Early Stage Investigator Award LectureLocation: International Center SouthAward Lecturer: – City University of New York
Award Presenter: – Washington State University
Physiological Based Pharmacokinetic Modeling and Simulation (PBPK)
Special Populations (SPO)
Zhu Zhou, PhD (she/her/hers) – City University of New York ### 830471###Award Lecturer###Associate Professor###City University of New York###Award Lecturer: – City University of New York
### she/her/hers @@@ Mary Paine, PhD, RPh – Washington State University ### 1818844###Award Presenter###Professor###Washington State University###Award Presenter: – Washington State University
### 3:30 PM – 4:15 PM MDT
Sheiner-Beal Pharmacometrics Award Lecture
3:30 PM – 4:15 PM MDT
Sheiner-Beal Pharmacometrics Award LectureLocation: International Center NorthAward Lecturer: – Novartis Pharma AG
Award Presenter: – Global Health Labs
Pharmacometrics & Pharmacokinetics (PMK)
Amy H. Racine-Poon, PhD – Novartis Pharma AG ### 2128781###Award Lecturer###Distinguished Scientist###Novartis Pharma AG###Award Lecturer: – Novartis Pharma AG
### @@@ Steven E. Kern, PhD (he/him/his) – Global Health Labs ### 1178577###Award Presenter###Executive Director###Global Health Labs###Award Presenter: – Global Health Labs
### he/him/his3:30 PM – 4:30 PM MDT
Harnessing the Power of Image-Based Biomarkers: Advancing Model-Informed Precision Medicine
3:30 PM – 4:30 PM MDT
Harnessing the Power of Image-Based Biomarkers: Advancing Model-Informed Precision MedicineLocation: Broadmoor Hall BChair: – Critical Path Institute
Chair: – Amgen
Speaker: – Quibim
Speaker: – University of Florida
Speaker: – University of Michigan
Pharmacometrics & Pharmacokinetics (PMK)
Translational Informatics (TI)
Jagdeep Podichetty, PhD – Critical Path Institute ### 1429068###Chair###Senior Director, Predictive Analytics###Critical Path Institute###Chair: – Critical Path Institute
### @@@ Jamie Connarn, PhD – Amgen ### 2278279###Chair###Senior Principal Scientist###Amgen###Chair: – Amgen
### @@@ Fuensanta Bellvís Bataller, MSc (she/her/hers) – Quibim ### 2273456###Speaker###VP of Clinical Studies###Quibim###Speaker: – Quibim
### she/her/hers @@@ Sarah Kim, PhD (she/her/hers) – University of Florida ### 1818861###Speaker###Assistant Professor###University of Florida###Speaker: – University of Florida
### she/her/hers @@@ Yuanfang Guan, PhD – University of Michigan ### 1186965###Speaker###Associate Professor###University of Michigan###Speaker: – University of Michigan
### 3:30 PM – 4:30 PM MDT
Oral Abstract I: Assessing Drug Safety in Special Populations
3:30 PM – 4:30 PM MDT
Oral Abstract I: Assessing Drug Safety in Special PopulationsLocation: Broadmoor Hall AChair: – Duke University
Chair: – US Food and Drug Administration
Daniel Gonzalez, PharmD, PhD (he/him/his) – Duke University ### 2121860###Chair###Instructor###Duke University###Chair: – Duke University
### he/him/his @@@ Elimika P. Pfuma Fletcher, PharmD, PhD (he/him/his) – US Food and Drug Administration ### 1819017###Chair###Policy Lead###US Food and Drug Administration###Chair: – US Food and Drug Administration
### he/him/his5:00 PM – 6:30 PM MDT
Meet ASCPT Leaders
5:00 PM – 6:30 PM MDT
Meet ASCPT LeadersLocation: Bartolin HallExpert: – Merck & Co.
Expert: – EMD Serono
Expert: – University of Montana
Expert: – GlaxoSmithKline
Expert: – Bill & Melinda Gates Foundation
Expert: – Thomas Jefferson University
Kathryn Momary-Carter, PharmD (she/her/hers) – Merck & Co. ### 926141###Expert###Senior Clinical Scientist###Merck & Co.###Expert: – Merck & Co.
### she/her/hers @@@ Lisa Benincosa – EMD Serono ### 1819331###Expert######EMD Serono###Expert: – EMD Serono
### @@@ Shayna R. Killam, MS, PharmD (she/her/hers) – University of Montana ### 1143999###Expert###Postdoctoral Fellow###University of Montana###Expert: – University of Montana
### she/her/hers @@@ Georgios Vlasakakis, PhD (he/him/his) – GlaxoSmithKline ### 1307126###Expert###Director Clinical Pharmacology###GlaxoSmithKline###Expert: – GlaxoSmithKline
### he/him/his @@@ Dan Hartman, MD (he/him/his) – Bill & Melinda Gates Foundation ### 949850###Expert###Director, Integrated Development; Global Health###Bill & Melinda Gates Foundation###Expert: – Bill & Melinda Gates Foundation
### he/him/his @@@ Walter Kraft, MD – Thomas Jefferson University ### 1436017###Expert###Professor###Thomas Jefferson University###Expert: – Thomas Jefferson University
### 5:00 PM – 6:30 PM MDT
Meet the Editors
5:00 PM – 6:30 PM MDT
Meet the Editors
Location: Bartolin Hall
5:00 PM – 6:30 PM MDT
Poster Session II
5:00 PM – 6:30 PM MDT
Poster Session II
Location: Bartolin Hall
5:00 PM – 6:30 PM MDT
President’s Networking Reception & Tournament of Champions brought to you by Gilead
5:00 PM – 6:30 PM MDT
President’s Networking Reception & Tournament of Champions brought to you by Gilead
Location: Bartolin Hall
5:20 PM – 5:50 PM MDT
Poster Walk I: Translational Approaches in Rare Diseases brought to you by Gilead
5:20 PM – 5:50 PM MDT
Poster Walk I: Translational Approaches in Rare Diseases brought to you by GileadLocation: Bartolin HallChair: – Children's Mercy - Kansas City
Chair: – University of Minnesota
Matthew McLaughlin, MD – Children's Mercy - Kansas City ### 925782###Chair###Associate Professor of Pediatrics###Children's Mercy - Kansas City###Chair: – Children's Mercy - Kansas City
### @@@ Melanie Nicol, PharmD, PhD (she/her/hers) – University of Minnesota ### 851988###Chair###Associate Professor###University of Minnesota###Chair: – University of Minnesota
### she/her/hers5:55 PM – 6:25 PM MDT
Poster Walk II: Application of Quantitative Approaches for Predicting Patient Outcomes brought to you by Johnson & Johnson
5:55 PM – 6:25 PM MDT
Poster Walk II: Application of Quantitative Approaches for Predicting Patient Outcomes brought to you by Johnson & JohnsonLocation: Bartolin HallChair: – iTeos Therapeutics
Chair: – Genentech
Angela J. James, PhD, MS (she/her/hers) – iTeos Therapeutics ### 956009###Chair###Vice President, Clinical Development ###iTeos Therapeutics###Chair: – iTeos Therapeutics
### she/her/hers @@@ Joseph Chen, PharmD – Genentech ### 1070921###Chair###Senior Principal Scientist###Genentech###Chair: – Genentech
### 6:30 PM – 7:30 PM MDT
Donor Reception (by invitation only) brought to you by ICON
6:30 PM – 7:30 PM MDT
Donor Reception (by invitation only) brought to you by ICON
Location: Robert Trent Jones, SR
